The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations AB Keenan, SL Jenkins, KM Jagodnik, S Koplev, E He, D Torre, Z Wang, ... Cell systems 6 (1), 13-24, 2018 | 414 | 2018 |
Intercellular coupling of the cell cycle and circadian clock in adult stem cell culture T Matsu-Ura, A Dovzhenok, E Aihara, J Rood, H Le, Y Ren, AE Rosselot, ... Molecular cell 64 (5), 900-912, 2016 | 127 | 2016 |
Connecting omics signatures and revealing biological mechanisms with iLINCS M Pilarczyk, M Fazel-Najafabadi, M Kouril, B Shamsaei, J Vasiliauskas, ... Nature communications 13 (1), 4678, 2022 | 52 | 2022 |
Connecting omics signatures of diseases, drugs, and mechanisms of actions with iLINCS M Pilarczyk, M Kouril, B Shamsaei, J Vasiliauskas, W Niu, N Mahi, ... BioRxiv, 826271, 2019 | 42 | 2019 |
Does secretin add value in pediatric magnetic resonance cholangiopancreatography? AT Trout, DJ Podberesky, SD Serai, Y Ren, M Altaye, AJ Towbin Pediatric radiology 43, 479-486, 2013 | 20 | 2013 |
Characterizing maternal glycemic control: a more informative approach using semiparametric regression R VanDyke, Y Ren, HJ Sucharew, M Miodovnik, B Rosenn, JC Khoury The Journal of Maternal-Fetal & Neonatal Medicine 25 (1), 15-19, 2012 | 13 | 2012 |
Predicting mechanism of action of cellular perturbations with pathway activity signatures Y Ren, S Sivaganesan, NA Clark, L Zhang, J Biesiada, W Niu, DR Plas, ... Bioinformatics, https://academic.oup.com/bioinformatics/, 2020 | 9 | 2020 |
Connecting omics signatures of diseases, drugs, and mechanisms of actions with iLINCS. bioRxiv, 826271 M Pilarczyk, MF Najafabadi, M Kouril, J Vasiliauskas, W Niu, B Shamsaei, ... | 6 | 2019 |
The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations. Cell Syst 2018; 6: 13–24 AB Keenan, SL Jenkins, KM Jagodnik, S Koplev, E He, D Torre, Z Wang, ... Duan, Q., Flynn, C., Niepel, M., Hafner, M., Muhlich, JL, Fernandez, NF …, 2014 | 6 | 2014 |
Connecting omics signatures of diseases, drugs, and mechanisms of actions with iLINCS. 2019; bioRxiv doi: 31 October 2019, preprint: not peer reviewedhttps M Pilarczyk, MF Najafabadi, M Kouril, J Vasiliauskas, W Niu, B Shamsaei, ... doi. org/10.1101/826271, 0 | 6 | |
Differences in peripheral immune system gene expression in frontotemporal degeneration RP Sawyer, EJ Hill, J Yokoyama, M Medvedovic, Y Ren, X Zhang, ... Medicine 101 (3), e28645, 2022 | 5 | 2022 |
Biclustering of medical monitoring data using a non‐parametric hierarchical Bayesian model Y Ren, S Sivaganesan, M Altaye, RS Amin, RD Szczesniak Stat 4 (279), 2020 | 5 | 2020 |
Finding clocks in genes: a Bayesian approach to estimate periodicity Y Ren, CI Hong, S Lim, S Song BioMed Research International 2016 (1), 3017475, 2016 | 5 | 2016 |
Axl regulated survival/proliferation network and its therapeutic intervention in mouse models of glomerulonephritis Y Zhen, Y Ren, M Medvedovic, DE Adams, D Wang, WH Shao Arthritis Research & Therapy 24 (1), 284, 2022 | 3 | 2022 |
Integrative signatures of signaling pathway response increase robustness and accuracy of pathway predictions NA Clark, Y Ren, DR Plas, S Sivaganesan, M Medvedovic bioRxiv, 2022.06. 03.494712, 2022 | | 2022 |
Using the castration resistant prostate cancer patient-derived xenograft (PDX) tumor model to identify mRNA/miRNA biomarkers which distinguish abiraterone treatment responders … B Ouyang, D Song, J Biesiada, Y Ren, M Medvedovic, P Tarapore CANCER RESEARCH 80 (21), 2020 | | 2020 |
Abstract PO-129: Using the castration resistant prostate cancer patient-derived xenograft (PDX) tumor model to identify mRNA/miRNA biomarkers which distinguish abiraterone … B Ouyang, D Song, J Biesiada, Y Ren, M Medvedovic, P Tarapore Cancer Research 80 (21_Supplement), PO-129-PO-129, 2020 | | 2020 |
Supplemental Results M Pilarczyk, M Fazel-Najafabadi, M Kouril, B Shamsaei, J Vasiliauskas, ... | | |